FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Comments Sought on Pregnancy Labeling Requirements

[ Price : $8.95]

Federal Register notice: FDA requests comments on an information collection extension for Content and Format of Labeling for Human...

CGMP Violations in Koreas Dasan E&T

[ Price : $8.95]

FDA warns Koreas Dasan E&T Co. about CGMP violations in its production of finished pharmaceuticals.

2 ANDA Guidances Out

[ Price : $8.95]

FDA issues two draft guidances clarifying changes made in the recent GDUFA reauthorization.

QS Issues Found in Diasol East Inspection

[ Price : $8.95]

FDA warns Diasol East about QS violations in its manufacturing of dialysis liquid and powder dialysate concentrate.

FDA Denies Without Comment Apotex Neulasta Petition

[ Price : $8.95]

FDA denies an Apotex petition asking it to set requirements for BLAs referencing Neulasta, and doesnt comment on whether it may ul...

3 MDUFA 4 Guidances Issued

[ Price : $8.95]

FDA issues three guidances explaining revised performance goal actions approved in the MDUFA 4 reauthorization for 510(k)s, PMAs, ...

9th Circuit Denies Gilead FCA Case Rehearing

[ Price : $8.95]

The 9th Circuit Court of Appeals declines to rehear a whistleblower case involving three Gilead HIV drugs.

Gottlieb Outlines Changes to Expanded Access Program

[ Price : $8.95]

FDA commissioner Scott Gottlieb says the agency is making changes to make it easier for patients to gain access to experimental th...

Joint FDA Panel to Review Braeburn Pharmaceuticals Drug

[ Price : $8.95]

Federal Register notice: An FDA advisory committee reviews a Braeburn Pharmaceuticals NDA for buprenorphine subcutaneous injection...

Latest FDA Warning Letters

[ Price : $8.95]

FDA releases its latest batch of Warning Letters that includes Dasan E&T Co. and Diasol East.